Opinions
John Hood
Ishares Trust S & P Global Healthcare Index
IXJ-N
BUY
Apr 13, 2015
$109.860
Stock price when the opinion was issued
E.T.F.'s
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
COMMENT
Healthcare has been one of the spaces that has had very good earnings growth in the S&P and probably global as well. A very stable space. Probably a little bit of a stretch in terms of valuation. He tends to like some of the biotech names. Feels healthcare will continue to run because of the need to own something more secure and put into things that have a nice dividend. Very little volatility.
E.T.F.'s
TOP PICK
Healthcare has both defensive characteristics + growth attributes. Includes medical devices, pharma, medicare, biotechnology. Usually strong balance sheets with lots of cash, paving the way for higher dividends, share buybacks, and M&A activity. Aging population and growing middle class enhance prospects for healthcare. 70% is in US names. JNJ, PFE, Roche Holdings, ABT, UNH. Yield is about 1.1%.
E.T.F.'s
BUY
Advertising
This is an interesting one and he has no problems with it. The one thing is that it is about 60% US, so it is not that much diversification on a global basis. Nothing wrong with that though.